Recent advances in therapeutic strategies for unresectable or metastatic melanoma and real-world data in Japan
Author:
Funder
Japan Society for the Promotion of Science
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology,General Medicine,Surgery
Link
http://link.springer.com/article/10.1007/s10147-018-1246-y/fulltext.html
Reference51 articles.
1. Mangana J, Cheng PF, Kaufmann C et al (2017) Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland. Melanoma Res 27(4):358–368
2. CANCER STATISTICS IN JAPAN '16. Cancer information service NCC, Japan. https://ganjoho.jp/en/professional/statistics/brochure/2016_en.html
3. Nishi M (2016) Epidemiology of skin cancer in Japan. J Tumor 4(2):369–373
4. Fujisawa Y, Fujimoto M (2014) Statistics for malignant melanoma in Japan: a nation wide survey from 2005 to 2013. Skin Cancer 29(2):189–194
5. Curtin JA, Fridlyand J, Kageshita T et al (2005) Distinct sets of genetic alterations in melanoma. N Engl J Med 353(20):2135–2147
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. An update on methods for detection of prognostic and predictive biomarkers in melanoma;Frontiers in Cell and Developmental Biology;2023-10-13
2. The role of mitochondria in the resistance of melanoma to PD-1 inhibitors;Journal of Translational Medicine;2023-05-23
3. Systematic review and network meta-analysis of drug combinations suggested by machine learning on genes and proteins, with the aim of improving the effectiveness of Ipilimumab in treating Melanoma;2023-05-14
4. IMUNOTERAPIA NO TRATAMENTO DO CÂNCER DE PELE: INIBIDORES DE CHECKPOINTS NO COMBATE AO MELANOMA;Revista interdisciplinar em saúde;2023-04-29
5. A Sulfur Containing Melanogenesis Substrate, N-Pr-4-S-CAP as a Potential Source for Selective Chemoimmunotherapy of Malignant Melanoma;International Journal of Molecular Sciences;2023-03-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3